Table 1 Intake and follow-up substance use disorders, mental health disorders, and clinical variables (n = 107)
Variable | Intake | Six months | ||
|---|---|---|---|---|
n | % | n | % | |
SUD a | ||||
Alcohol | 47 | 43.9 | 31 | 29.0 |
Cocaine | 34 | 31.8 | 17 | 15.9 |
Heroin | 13 | 12.1 | 19 | 17.8 |
Cannabis | 30 | 28.0 | 5 | 4.7 |
Benzodiazepine | 19 | 17.8 | 12 | 11.2 |
Tranquilizer | 7 | 6.5 | 2 | 1.9 |
Mental Health Screening a | ||||
Neurodevelopment | 18 | 16.8 | -- | -- |
Schizophrenia | 6 | 5.6 | -- | -- |
Bipolar | 21 | 19.6 | -- | -- |
Depression | 41 | 38.3 | -- | -- |
Anxiety | 13 | 12.1 | -- | -- |
Trauma | 78 | 72.9 | -- | -- |
Disruptive | 11 | 10.3 | -- | -- |
Substance use | 99 | 92.5 | -- | -- |
Personality | 20 | 18.7 | -- | -- |
Suicidal Behavior | 8 | 7.5 | -- | -- |
Clinical variables a | ||||
HIV + | 16 | 15.0 | -- | -- |
HBV + | 3 | 2.8 | -- | -- |
HCV + | 11 | 10.3 | -- | -- |